Misoprostol rectally in uterine atony unresponsive to conventional treatment.

• Autores: Sandoval, José, Gutiérrez, Miguel, Díaz, Nancy, Paz, Patricia
• Formato: artículo
• Fecha de Publicación: 2015
• Institución: Sociedad Peruana de Obstetricia y Ginecología
• Repositorio: Revista SPOG - Revista Peruana de Ginecología y Obstetricia
• Lenguaje: español
• OAI Identifier: oai:ojs.spog:article/1417
• Enlace del recurso: http://www.spog.org.pe/web/revista/index.php/RPGO/article/view/1417
• Nivel de acceso: acceso abierto

OBJECTIVES: To evaluate the efficacy, tolerability and safety of misoprostol rectally to control uterine atony. DESIGN: clinical trial. PLACE: National Hospital "Sergio E. Bernales" Collique, Lima, during the period September 1998 to December 1999. MATERIAL AND METHODS: Patients who had postpartum hemorrhage (PPH) by uterine inertia, which persists despite the application of uterine massage , oxytocics and ergot. Seven patients were administered 800 mcg of misoprostol in the rectal vault, and every 5 minutes an additional 200 mg was added if bleeding persisted. RESULTS: In 7 patients the bleeding was controlled by an average of 5.8 minutes. In no case they were presented side effects. It was applied in only 3 patients 800 ug and 1000 ug 4 women total dose of misoprostol. By severe hemorrhage in 7 cases hemoglobin dropped an average of 3.4 mg%. CONCLUSIONS: Misoprostol rectally is effective, safe and well tolerated to control PPH from uterine atony. It comes as a great alternative to control PPH problems in remote areas do not have adequate technical resources.